ABEC Inaugurates Cutting-Edge Bioprocess Manufacturing Facility in North Carolina
On September 10, 2026, ABEC, an industry frontrunner in tailored solutions for biopharmaceutical manufacturing, announced the forthcoming grand opening of its pioneering manufacturing facility located in Wilson, North Carolina. The grand event is set for September 24, 2026, starting at 9:00 AM, and will see the gathering of key stakeholders including company executives, employees, partners, and community leaders who will celebrate this vital step in ABEC’s expansion journey.
The establishment of this facility is not merely a company milestone but represents a significant boost to the biopharmaceutical industry across the southeastern United States. Positioned strategically in one of the country’s most rapidly developing life sciences hubs, the Wilson facility will significantly optimize ABEC’s manufacturing capabilities, enabling the company to continue delivering superior products and integrated solutions tailored to biopharmaceutical processes.
Scott Pickering, CEO of ABEC, emphasized the importance of this new site, stating, "Opening our Wilson facility represents another crucial milestone in ABEC's commitment to supporting the global biopharmaceutical industry. This investment expands our manufacturing capabilities, brings us closer to customers in the southeastern United States, and reinforces our ability to deliver the industry's most comprehensive portfolio of bioprocess equipment, consumables, and engineering solutions."
The Wilson facility is set to manufacture a variety of bioprocess equipment and consumable products that are essential in the development and production of critical biologics, vaccines, and other advanced medicines. This site will complement ABEC’s operational network which includes existing manufacturing units in Bethlehem, Pennsylvania; Springfield, Missouri; Fermoy, Ireland; and Kells, Ireland, thereby solidifying the company's position as the foremost dedicated manufacturing network for process equipment and solutions in the biopharmaceutical industry.
During the grand opening, attendees will be treated to a comprehensive experience, including a ceremonial ribbon-cutting, facility tours, and speeches from ABEC leadership along with local community dignitaries. The celebration will also acknowledge the collaborative effort of employees, contractors, and community partners whose support has been paramount in realizing this project.
ABEC has earned its position as a global leader since its inception in 1974, providing engineering solutions and services tailored to the biotech sector. With a wide range of pharmaceutical and biotechnology firms among its clientele, many of the most significant therapies being produced globally rely on equipment engineered by ABEC. The core of ABEC’s unique value lies in its vast experience, extensive in-house capabilities, flexible approach, and a proven track record of credibility in the market.
From aiding in process development to facility design, equipment fabrication, and ongoing support, ABEC is committed to helping its customers minimize costs and expedite time-to-market while maximizing productivity. This new facility is a testament to this commitment and is a promise of enhanced service delivery for the biopharmaceutical field.
To learn more about ABEC and their innovative solutions designed for biotech manufacturing, please visit their official website.
The opening of ABEC's facility in Wilson, North Carolina, not only marks a pivotal growth phase for the company but also signifies a broader advancement for the biopharmaceutical industry in the region.
This development is bound to create numerous job opportunities for skilled professionals in eastern North Carolina, further establishing the area as a key player in biomanufacturing. The community and local stakeholders have shown overwhelming support for this initiative, which is anticipated to accelerate the region’s economic growth and innovation in the life sciences sector.
The establishment of this facility is not merely a company milestone but represents a significant boost to the biopharmaceutical industry across the southeastern United States. Positioned strategically in one of the country’s most rapidly developing life sciences hubs, the Wilson facility will significantly optimize ABEC’s manufacturing capabilities, enabling the company to continue delivering superior products and integrated solutions tailored to biopharmaceutical processes.
Scott Pickering, CEO of ABEC, emphasized the importance of this new site, stating, "Opening our Wilson facility represents another crucial milestone in ABEC's commitment to supporting the global biopharmaceutical industry. This investment expands our manufacturing capabilities, brings us closer to customers in the southeastern United States, and reinforces our ability to deliver the industry's most comprehensive portfolio of bioprocess equipment, consumables, and engineering solutions."
The Wilson facility is set to manufacture a variety of bioprocess equipment and consumable products that are essential in the development and production of critical biologics, vaccines, and other advanced medicines. This site will complement ABEC’s operational network which includes existing manufacturing units in Bethlehem, Pennsylvania; Springfield, Missouri; Fermoy, Ireland; and Kells, Ireland, thereby solidifying the company's position as the foremost dedicated manufacturing network for process equipment and solutions in the biopharmaceutical industry.
During the grand opening, attendees will be treated to a comprehensive experience, including a ceremonial ribbon-cutting, facility tours, and speeches from ABEC leadership along with local community dignitaries. The celebration will also acknowledge the collaborative effort of employees, contractors, and community partners whose support has been paramount in realizing this project.
ABEC has earned its position as a global leader since its inception in 1974, providing engineering solutions and services tailored to the biotech sector. With a wide range of pharmaceutical and biotechnology firms among its clientele, many of the most significant therapies being produced globally rely on equipment engineered by ABEC. The core of ABEC’s unique value lies in its vast experience, extensive in-house capabilities, flexible approach, and a proven track record of credibility in the market.
From aiding in process development to facility design, equipment fabrication, and ongoing support, ABEC is committed to helping its customers minimize costs and expedite time-to-market while maximizing productivity. This new facility is a testament to this commitment and is a promise of enhanced service delivery for the biopharmaceutical field.
To learn more about ABEC and their innovative solutions designed for biotech manufacturing, please visit their official website.
Conclusion
The opening of ABEC's facility in Wilson, North Carolina, not only marks a pivotal growth phase for the company but also signifies a broader advancement for the biopharmaceutical industry in the region.
This development is bound to create numerous job opportunities for skilled professionals in eastern North Carolina, further establishing the area as a key player in biomanufacturing. The community and local stakeholders have shown overwhelming support for this initiative, which is anticipated to accelerate the region’s economic growth and innovation in the life sciences sector.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.